Form4insider filings, from the source

SEC Form 4 · accession 0000886163-15-000090

LIGAND PHARMACEUTICALS INC · LGND

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Todd C Davis
Director
Period of report
Aug 6, 2015
Accepted (ET)
Aug 6, 2015 · 7:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 6, 2015M2,500$17.88A38,279D
Common StockAug 6, 2015M2,500$8.58A40,779D
Common StockAug 6, 2015M7,335$10.12A48,114D
Common StockAug 6, 2015M7,335$12.53A55,449D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F1$8.58Aug 6, 2015M2,500D—May 25, 2020Common Stock2,5000D
Non-Qualified Stock Option (right to buy)F2$10.12Aug 6, 2015M7,335D—Jun 1, 2021Common Stock7,3350D
Non-Qualified Stock Option (right to buy)F3$12.53Aug 6, 2015M7,335D—May 31, 2022Common Stock7,3350D
Non-Qualified Stock Option (right to buy)F4$17.88Aug 6, 2015M2,500D—May 29, 2019Common Stock2,5000D

Explanation of responses